Fig 1.
The nutritional pathway implemented based on nutritional guidance by the Shizuoka Cancer Center blood and hematopoietic cell transplantation team.
Table 1.
Nutrition-related adverse events according to the CTCAE and PS.
Table 2.
Eastern Cooperative Oncology Group (ECOG) performance status.
Fig 2.
Flowchart of the patient selection and enrollment process.
Table 3.
Patient background.
Table 4.
Clinical indicators assessed during the nutritional pathway evaluation.
Fig 3.
Weight loss rate: %LBW, skeletal muscle loss rate: %LSMM, and basal metabolic calorie sufficiency rate: BEE rate from T1 to T2.
Fig 4.
Grip and pinch strength and salivary amylase activity values at T1, on the engraftment date, and at T2.
Lower right photo: Left, grip strength meter; upper right, salivary amylase monitor; lower right, pinch strength meter.
Fig 5.
Receiver operating characteristic curve for weight loss and basal energy expenditure sufficiency rate from T1 to T2.
Fig 6.
Association between two-year survival, mortality, and clinical indicators.
Fig 7.
Nutrition-related adverse events and oral caloric intake from T1 to T2 and standard weight and performance status assessments over time.
Fig 8.
Changes in and associations with serum albumin and C-reactive protein values.